Exact Mass: 604.4342

Ginsenoside Rh3

C36H60O7 (604.4339)

Ginsenoside Rh3 is found in tea. Ginsenoside Rh3 is isolated from ginseng. Isolated from ginseng. Ginsenoside Rh3 is found in tea.

Cycloartanyl ferulate

C40H60O4 (604.4491)

Cycloartanyl ferulate is found in cereals and cereal products. Cycloartanyl ferulate is a constituent of rice bran oil Constituent of rice bran oil. Cycloartanyl ferulate is found in cereals and cereal products and fats and oils.

Hebevinoside IV

C36H60O7 (604.4339)

Toxic constituent of the toxic mushrrom Hebeloma vinosophyllum. Hebevinoside IV is found in mushrooms. Hebevinoside IV is found in mushrooms. Toxic constituent of the toxic mushrrom Hebeloma vinosophyllu

PA(15:0/14:1(9Z))

C32H61O8P (604.4104)

PA(15:0/14:1(9Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(15:0/14:1(9Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

Polyoxyethylene sorbitan monooleate

C32H60O10 (604.4186)

DG(13:0/PGJ2/0:0)

C36H60O7 (604.4339)

DG(13:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGJ2/13:0/0:0)

C36H60O7 (604.4339)

DG(PGJ2/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/PGJ2)

C36H60O7 (604.4339)

DG(13:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGJ2/0:0/13:0)

C36H60O7 (604.4339)

DG(PGJ2/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C37H64O6 (604.4703)

DG(14:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/14:0/0:0)

C37H64O6 (604.4703)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C37H64O6 (604.4703)

DG(14:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/14:0)

C37H64O6 (604.4703)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C37H64O6 (604.4703)

DG(14:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/14:0/0:0)

C37H64O6 (604.4703)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C37H64O6 (604.4703)

DG(14:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/14:0)

C37H64O6 (604.4703)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C37H64O6 (604.4703)

DG(14:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/14:0/0:0)

C37H64O6 (604.4703)

DG(20:3(5Z,11Z,14Z)-O(8,9)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C37H64O6 (604.4703)

DG(14:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/14:0)

C37H64O6 (604.4703)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C37H64O6 (604.4703)

DG(14:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/14:0/0:0)

C37H64O6 (604.4703)

DG(20:3(8Z,11Z,14Z)-O(5,6)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C37H64O6 (604.4703)

DG(14:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/14:0)

C37H64O6 (604.4703)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C37H64O6 (604.4703)

DG(14:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C37H64O6 (604.4703)

DG(14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/14:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C37H64O6 (604.4703)

DG(14:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C37H64O6 (604.4703)

DG(14:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/14:0)

C37H64O6 (604.4703)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C37H64O6 (604.4703)

DG(14:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C37H64O6 (604.4703)

DG(14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/14:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C37H64O6 (604.4703)

DG(14:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C37H64O6 (604.4703)

DG(14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/14:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C37H64O6 (604.4703)

DG(14:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C37H64O6 (604.4703)

DG(14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/14:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C37H64O6 (604.4703)

DG(14:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C37H64O6 (604.4703)

DG(14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/14:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C37H64O6 (604.4703)

DG(14:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C37H64O6 (604.4703)

DG(14:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/14:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C37H64O6 (604.4703)

DG(14:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C37H64O6 (604.4703)

DG(14:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/14:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C37H64O6 (604.4703)

DG(14:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C37H64O6 (604.4703)

DG(14:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/14:0)

C37H64O6 (604.4703)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(14:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C37H64O6 (604.4703)

DG(14:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(14:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(14:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C37H64O6 (604.4703)

DG(14:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/14:0)

C37H64O6 (604.4703)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/PGJ2/0:0)

C36H60O7 (604.4339)

DG(a-13:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGJ2/a-13:0/0:0)

C36H60O7 (604.4339)

DG(PGJ2/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/PGJ2)

C36H60O7 (604.4339)

DG(a-13:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGJ2/0:0/a-13:0)

C36H60O7 (604.4339)

DG(PGJ2/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/PGJ2/0:0)

C36H60O7 (604.4339)

DG(i-13:0/PGJ2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/PGJ2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGJ2/i-13:0/0:0)

C36H60O7 (604.4339)

DG(PGJ2/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGJ2/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/PGJ2)

C36H60O7 (604.4339)

DG(i-13:0/0:0/PGJ2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGJ2/0:0/i-13:0)

C36H60O7 (604.4339)

DG(PGJ2/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C37H64O6 (604.4703)

DG(i-14:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-14:0/0:0)

C37H64O6 (604.4703)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C37H64O6 (604.4703)

DG(i-14:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-14:0)

C37H64O6 (604.4703)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C37H64O6 (604.4703)

DG(i-14:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-14:0/0:0)

C37H64O6 (604.4703)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C37H64O6 (604.4703)

DG(i-14:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-14:0)

C37H64O6 (604.4703)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C37H64O6 (604.4703)

DG(i-14:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-14:0/0:0)

C37H64O6 (604.4703)

DG(20:3(5Z,11Z,14Z)-O(8,9)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C37H64O6 (604.4703)

DG(i-14:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-14:0)

C37H64O6 (604.4703)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C37H64O6 (604.4703)

DG(i-14:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-14:0/0:0)

C37H64O6 (604.4703)

DG(20:3(8Z,11Z,14Z)-O(5,6)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C37H64O6 (604.4703)

DG(i-14:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-14:0)

C37H64O6 (604.4703)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C37H64O6 (604.4703)

DG(i-14:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C37H64O6 (604.4703)

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-14:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C37H64O6 (604.4703)

DG(i-14:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C37H64O6 (604.4703)

DG(i-14:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-14:0)

C37H64O6 (604.4703)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C37H64O6 (604.4703)

DG(i-14:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C37H64O6 (604.4703)

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-14:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C37H64O6 (604.4703)

DG(i-14:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C37H64O6 (604.4703)

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-14:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C37H64O6 (604.4703)

DG(i-14:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C37H64O6 (604.4703)

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-14:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C37H64O6 (604.4703)

DG(i-14:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-14:0/0:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-14:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/i-14:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C37H64O6 (604.4703)

DG(i-14:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-14:0)

C37H64O6 (604.4703)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/i-14:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-14:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C37H64O6 (604.4703)

DG(i-14:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-14:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

Ginsenoside Rh3

C36H60O7 (604.4339)

Ginsenoside Rh3 is a triterpenoid saponin. Ginsenoside Rh3 is a natural product found in Panax ginseng and Panax notoginseng with data available. Annotation level-1

Ginsenoside RK2

C36H60O7 (604.4339)

Ginsenoside Rk2 is a natural product found in Panax ginseng and Panax notoginseng with data available.

trans-Securinegin

C40H60O4 (604.4491)

Erythrodiol 3-caffeate

C39H56O5 (604.4128)

Uvaol 3-caffeate

C39H56O5 (604.4128)

Betulin 3-caffeate

C39H56O5 (604.4128)

(3S,4R,5S,6S,3S,4R,5S,6S)-5,6,5,6-tetrahydro-beta,beta-carotene-3,4,3,4-tetrol

C40H60O4 (604.4491)

Ipomoeaxanthin B

C40H60O4 (604.4491)

cis-Securinegin

C40H60O4 (604.4491)

frutoic acid

C40H60O4 (604.4491)

C36H60O7

C36H60O7 (604.4339)

Cammeliagenin-A-16-O-cinnamat, 3beta,16alpha,22alpha,28-Tetrahydroxy-Delta12-oleanen-16-O-cinnamat

C39H56O5 (604.4128)

C40H60O4

C40H60O4 (604.4491)

3beta-caffeoyloxylup-20(29)-en-6alpha-ol

C39H56O5 (604.4128)

Acritopappuslactone A

C40H60O4 (604.4491)

24-methylenecycloartane-3beta,6beta,7beta-triol 3-Obeta-D-xylopyranoside

C36H60O7 (604.4339)

3alpha-(E)-caffeoyloxyfriedelan-7-one

C39H56O5 (604.4128)

21alpha,24-dihydroxyserrat-14-en-3beta-yl 4-hydroxycinnamate|lycophlegmarinol C

C39H56O5 (604.4128)

24-methylenecycloartane-3beta,6beta,16beta-triol 3-Obeta-D-xylopyranoside

C36H60O7 (604.4339)

16alpha-hydroxyolean-12-ene 3-O-glucoside

C36H60O7 (604.4339)

24-methylenecycloartane-3beta,7beta,16beta-triol 3-Obeta-D-xylopyranoside

C36H60O7 (604.4339)

1beta-hydroxylup-20(29)-en-3beta-yl caffeate

C39H56O5 (604.4128)

lanceolatic acid

C40H60O4 (604.4491)

3beta-O-cis-coumaroylbetulin

C40H60O4 (604.4491)

Magtenon|Maytenon

C40H60O4 (604.4491)

PE-Cer(d14:1/16:0)

C32H65N2O6P (604.458)

PA(12:0/17:1(9Z))

C32H61O8P (604.4104)

PA(13:0/16:1(9Z))

C32H61O8P (604.4104)

PA(14:0/15:1(9Z))

C32H61O8P (604.4104)

PA(14:1(9Z)/15:0)

C32H61O8P (604.4104)

PA(15:0/14:1(9Z))

C32H61O8P (604.4104)

PA(15:1(9Z)/14:0)

C32H61O8P (604.4104)

PA(16:1(9Z)/13:0)

C32H61O8P (604.4104)

PA(17:1(9Z)/12:0)

C32H61O8P (604.4104)

PA(O-16:0/14:1(9Z))

C33H65O7P (604.4468)

PA(P-16:0/14:0)

C33H65O7P (604.4468)

PA(P-18:0/12:0)

C33H65O7P (604.4468)

Hebevinoside IV

C36H60O7 (604.4339)

Cycloartanyl ferulate

C40H60O4 (604.4491)

PA 29:1

C32H61O8P (604.4104)

PA O-30:1

C33H65O7P (604.4468)

CerPE 30:1;O2

C32H65N2O6P (604.458)

3,4,3,4-Tetrahydroxypirardixanthin

C40H60O4 (604.4491)

7,8,7,8-Tetrahydrocapsorubin

C40H60O4 (604.4491)

sodium dilinoleate

C36H62Na2O4 (604.4443)

Isoginsenoside Rh3

C36H60O7 (604.4339)

2-[2-[3,4-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy]ethyl (E)-octadec-9-enoate

C32H60O10 (604.4186)

DG(13:0/PGJ2/0:0)

C36H60O7 (604.4339)

DG(PGJ2/13:0/0:0)

C36H60O7 (604.4339)

DG(13:0/0:0/PGJ2)

C36H60O7 (604.4339)

DG(PGJ2/0:0/13:0)

C36H60O7 (604.4339)

DG(a-13:0/PGJ2/0:0)

C36H60O7 (604.4339)

DG(PGJ2/a-13:0/0:0)

C36H60O7 (604.4339)

DG(a-13:0/0:0/PGJ2)

C36H60O7 (604.4339)

DG(PGJ2/0:0/a-13:0)

C36H60O7 (604.4339)

DG(i-13:0/PGJ2/0:0)

C36H60O7 (604.4339)

DG(PGJ2/i-13:0/0:0)

C36H60O7 (604.4339)

DG(i-13:0/0:0/PGJ2)

C36H60O7 (604.4339)

DG(PGJ2/0:0/i-13:0)

C36H60O7 (604.4339)

WURCS=2.0/1,1,0/[hx12xh_3-6_1*OCCOCCCCCCCCC=^ZCCCCCCCCC/6=O_2*OCCO_4*OCCO_5*OCCO]/1

C32H60O10 (604.4186)

1-Heptadecanoyl-2-lauroyl-sn-glycero-3-phosphate(2-)

C32H61O8P-2 (604.4104)

CID 154573493

C32H63NO7P+ (604.4342)

(2S,3R,4S,5R)-2-[[(7R,9R,10R,13R,14S,16R,17R)-16-hydroxy-7-methoxy-4,4,9,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol

C36H60O7 (604.4339)

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(8R,10R,12S,13R,14S,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2Z)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol

C36H60O7 (604.4339)

NAGlySer 13:1/16:3

C34H56N2O7 (604.4087)

NAGlySer 16:4/13:0

C34H56N2O7 (604.4087)

NAGlySer 18:4/11:0

C34H56N2O7 (604.4087)

NAGlySer 16:3/13:1

C34H56N2O7 (604.4087)

2,3-dihydroxypropyl [3-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]-2-hydroxypropyl] hydrogen phosphate

C32H61O8P (604.4104)

Mgdg O-9:0_15:0

C33H64O9 (604.455)

Mgdg O-19:0_5:0

C33H64O9 (604.455)

Mgdg O-22:0_2:0

C33H64O9 (604.455)

Mgdg O-8:0_16:0

C33H64O9 (604.455)

Mgdg O-21:0_3:0

C33H64O9 (604.455)

Mgdg O-16:0_8:0

C33H64O9 (604.455)

Mgdg O-17:0_7:0

C33H64O9 (604.455)

Mgdg O-20:0_4:0

C33H64O9 (604.455)

Mgdg O-15:0_9:0

C33H64O9 (604.455)

Mgdg O-18:0_6:0

C33H64O9 (604.455)

Mgdg O-11:0_13:0

C33H64O9 (604.455)

Mgdg O-12:0_12:0

C33H64O9 (604.455)

Mgdg O-10:0_14:0

C33H64O9 (604.455)

Mgdg O-14:0_10:0

C33H64O9 (604.455)

Mgdg O-13:0_11:0

C33H64O9 (604.455)

PE-Cer 13:0;2O/17:1

C32H65N2O6P (604.458)

PE-Cer 18:1;2O/12:0

C32H65N2O6P (604.458)

PE-Cer 15:1;2O/15:0

C32H65N2O6P (604.458)

PE-Cer 14:0;2O/16:1

C32H65N2O6P (604.458)

PE-Cer 13:1;2O/17:0

C32H65N2O6P (604.458)

PE-Cer 12:1;2O/18:0

C32H65N2O6P (604.458)

PE-Cer 16:0;2O/14:1

C32H65N2O6P (604.458)

PE-Cer 15:0;2O/15:1

C32H65N2O6P (604.458)

PE-Cer 17:1;2O/13:0

C32H65N2O6P (604.458)

PE-Cer 16:1;2O/14:0

C32H65N2O6P (604.458)

PE-Cer 17:0;2O/13:1

C32H65N2O6P (604.458)

PE-Cer 12:0;2O/18:1

C32H65N2O6P (604.458)

PE-Cer 14:1;2O/16:0

C32H65N2O6P (604.458)

PE-Cer 13:1;2O/16:1;O

C31H61N2O7P (604.4216)

PE-Cer 14:2;2O/15:0;O

C31H61N2O7P (604.4216)

PE-Cer 12:2;2O/17:0;O

C31H61N2O7P (604.4216)

PE-Cer 17:2;2O/12:0;O

C31H61N2O7P (604.4216)

PE-Cer 15:2;2O/14:0;O

C31H61N2O7P (604.4216)

PE-Cer 16:1;2O/13:1;O

C31H61N2O7P (604.4216)

PE-Cer 17:1;2O/12:1;O

C31H61N2O7P (604.4216)

PE-Cer 14:1;2O/15:1;O

C31H61N2O7P (604.4216)

PE-Cer 16:2;2O/13:0;O

C31H61N2O7P (604.4216)

PE-Cer 13:0;2O/16:2;O

C31H61N2O7P (604.4216)

PE-Cer 13:2;2O/16:0;O

C31H61N2O7P (604.4216)

PE-Cer 15:1;2O/14:1;O

C31H61N2O7P (604.4216)

[(E)-2-acetamido-3-hydroxypentacos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-3-hydroxy-2-(propanoylamino)tetracos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-3-hydroxy-2-(octadecanoylamino)non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-3-hydroxy-2-(octanoylamino)nonadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-2-(heptanoylamino)-3-hydroxyicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-3-hydroxy-2-(nonadecanoylamino)oct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-3-hydroxy-2-(nonanoylamino)octadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-2-(hexanoylamino)-3-hydroxyhenicos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]nonyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-2-(butanoylamino)-3-hydroxytricos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-3-hydroxy-2-(pentanoylamino)docos-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-2-(heptadecanoylamino)-3-hydroxydec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-2-(hexadecanoylamino)-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-2-(decanoylamino)-3-hydroxyheptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-3-hydroxy-2-(pentadecanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-3-hydroxy-2-(undecanoylamino)hexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxyundecyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]tridecyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-3-hydroxy-2-(tetradecanoylamino)tridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]dodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

PEtOH 13:0_14:1

C32H61O8P (604.4104)

PMeOH 15:0_13:1

C32H61O8P (604.4104)

PEtOH 14:0_13:1

C32H61O8P (604.4104)

PMeOH 12:0_16:1

C32H61O8P (604.4104)

PMeOH 13:0_15:1

C32H61O8P (604.4104)

PEtOH 12:0_15:1

C32H61O8P (604.4104)

PMeOH 14:0_14:1

C32H61O8P (604.4104)

Fahfa 18:5/22:4

C40H60O4 (604.4491)

Fahfa 18:4/22:5

C40H60O4 (604.4491)

[3-hydroxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropyl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C39H56O5 (604.4128)

Fahfa 22:6/18:3

C40H60O4 (604.4491)

Fahfa 20:5/20:4

C40H60O4 (604.4491)

[1-Heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] hexadecanoate

C32H60O10 (604.4186)

[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] nonadecanoate

C32H60O10 (604.4186)

[1-Acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] henicosanoate

C32H60O10 (604.4186)

[1-Hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] heptadecanoate

C32H60O10 (604.4186)

[1-Octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] pentadecanoate

C32H60O10 (604.4186)

[1-Nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetradecanoate

C32H60O10 (604.4186)

[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] octadecanoate

C32H60O10 (604.4186)

[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] icosanoate

C32H60O10 (604.4186)

[1-Decanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tridecanoate

C32H60O10 (604.4186)

[1-[3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] dodecanoate

C32H60O10 (604.4186)

[3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]octyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-3-hydroxy-2-(tridecanoylamino)tetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(E)-2-(dodecanoylamino)-3-hydroxypentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

(1-phosphonooxy-3-propanoyloxypropan-2-yl) (Z)-hexacos-15-enoate

C32H61O8P (604.4104)

(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (Z)-docos-13-enoate

C32H61O8P (604.4104)

(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (Z)-icos-11-enoate

C32H61O8P (604.4104)

(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tetracos-13-enoate

C32H61O8P (604.4104)

(1-octanoyloxy-3-phosphonooxypropan-2-yl) (Z)-henicos-11-enoate

C32H61O8P (604.4104)

(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (Z)-pentadec-9-enoate

C32H61O8P (604.4104)

[3-phosphonooxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] pentadecanoate

C32H61O8P (604.4104)

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (Z)-octadec-9-enoate

C32H61O8P (604.4104)

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-heptadec-9-enoate

C32H61O8P (604.4104)

[3-phosphonooxy-2-[(Z)-tridec-9-enoyl]oxypropyl] hexadecanoate

C32H61O8P (604.4104)

(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (Z)-hexadec-9-enoate

C32H61O8P (604.4104)

(1-decanoyloxy-3-phosphonooxypropan-2-yl) (Z)-nonadec-9-enoate

C32H61O8P (604.4104)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-octadec-9-enoate

C32H61O8P (604.4104)

[3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxypentadecyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

N-(tridecanoyl)-4E-tetradecasphingenine-1-phosphocholine

C32H65N2O6P (604.458)

N-(decanoyl)-4E-heptadecasphingenine-1-phosphocholine

C32H65N2O6P (604.458)

N-(dodecanoyl)-4E-pentadecasphingenine-1-phosphocholine

C32H65N2O6P (604.458)

[(2S)-1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-undecanoyloxypropan-2-yl] dodecanoate

C32H60O10 (604.4186)

[1-carboxy-3-[3-[(11E,14E,17E,20E,23E)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

C36H62NO6+ (604.4577)

[(2R)-1-phosphonooxy-3-tetradecanoyloxypropan-2-yl] (E)-pentadec-9-enoate

C32H61O8P (604.4104)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-hexadec-7-enoate

C32H61O8P (604.4104)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] octadec-17-enoate

C32H61O8P (604.4104)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-octadec-7-enoate

C32H61O8P (604.4104)

[(2S)-1-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tridecanoate

C32H60O10 (604.4186)

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] pentadecanoate

C32H61O8P (604.4104)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-octadec-11-enoate

C32H61O8P (604.4104)

[(E,2S,3R)-2-(decanoylamino)-3-hydroxyheptadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] pentadecanoate

C32H61O8P (604.4104)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] octadec-17-enoate

C32H61O8P (604.4104)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-octadec-7-enoate

C32H61O8P (604.4104)

[(2R)-1-dodecanoyloxy-3-phosphonooxypropan-2-yl] (E)-heptadec-9-enoate

C32H61O8P (604.4104)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-octadec-4-enoate

C32H61O8P (604.4104)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-octadec-11-enoate

C32H61O8P (604.4104)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-octadec-13-enoate

C32H61O8P (604.4104)

[(2S)-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-undecanoyloxypropyl] dodecanoate

C32H60O10 (604.4186)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-hexadec-9-enoate

C32H61O8P (604.4104)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-octadec-6-enoate

C32H61O8P (604.4104)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-hexadec-9-enoate

C32H61O8P (604.4104)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-octadec-13-enoate

C32H61O8P (604.4104)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-hexadec-7-enoate

C32H61O8P (604.4104)

[(E,2S,3R)-3-hydroxy-2-(tridecanoylamino)tetradec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[(2S)-2-decanoyloxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] tridecanoate

C32H60O10 (604.4186)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-octadec-4-enoate

C32H61O8P (604.4104)

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium

C35H58NO7+ (604.4213)

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]propyl]-trimethylazanium

C35H58NO7+ (604.4213)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-octadec-9-enoate

C32H61O8P (604.4104)

[1-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-hydroxypropan-2-yl] (5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoate

C39H56O5 (604.4128)

[(2R)-2-dodecanoyloxy-3-phosphonooxypropyl] (E)-heptadec-9-enoate

C32H61O8P (604.4104)

[(2R)-3-phosphonooxy-2-tetradecanoyloxypropyl] (E)-pentadec-9-enoate

C32H61O8P (604.4104)

[(E,2S,3R)-2-(dodecanoylamino)-3-hydroxypentadec-8-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C32H65N2O6P (604.458)

[1-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-hydroxypropan-2-yl] (7E,9E,11E,13E,15E,17E)-icosa-7,9,11,13,15,17-hexaenoate

C39H56O5 (604.4128)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-octadec-6-enoate

C32H61O8P (604.4104)

[1-carboxy-3-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-propanoyloxypropoxy]propyl]-trimethylazanium

C35H58NO7+ (604.4213)

2-[hydroxy-[2-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H63NO7P+ (604.4342)

[1-carboxy-3-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-pentanoyloxypropoxy]propyl]-trimethylazanium

C35H58NO7+ (604.4213)

[1-carboxy-3-[3-heptanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]propyl]-trimethylazanium

C35H58NO7+ (604.4213)

2-[[2-hexanoyloxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO7P+ (604.4342)

2-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-octanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO7P+ (604.4342)

2-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-octoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO7P+ (604.4342)

2-[[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO7P+ (604.4342)

2-[[3-[(9Z,12Z)-heptadeca-9,12-dienoxy]-2-heptanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO7P+ (604.4342)

2-[[2-butanoyloxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO7P+ (604.4342)

2-[hydroxy-[3-[(9Z,12Z)-nonadeca-9,12-dienoxy]-2-pentanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C32H63NO7P+ (604.4342)

2-[[2-acetyloxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C32H63NO7P+ (604.4342)

1-(1Z-octadecenyl)-2-dodecanoyl-glycero-3-phosphate

C33H65O7P (604.4468)

1-hexadecyl-2-(9Z-tetradecenoyl)-glycero-3-phosphate

C33H65O7P (604.4468)

1-Heptadecanoyl-2-lauroyl-sn-glycero-3-phosphate(2-)

C32H61O8P (604.4104)

A 1,2-diacyl-sn-glycerol 3-phosphate(2-) in which the phosphatidyl acyl groups at postions 1 and 2 are specified as heptadecanoyl and lauroyl respectively.

PEt(28:1)

C33H65O7P (604.4468)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

FAHFA 14:2/O-26:7

C40H60O4 (604.4491)

FAHFA 14:3/O-26:6

C40H60O4 (604.4491)

FAHFA 14:4/O-26:5

C40H60O4 (604.4491)

FAHFA 15:2/O-25:7

C40H60O4 (604.4491)

FAHFA 15:3/O-25:6

C40H60O4 (604.4491)

FAHFA 15:4/O-25:5

C40H60O4 (604.4491)

FAHFA 15:5/O-25:4

C40H60O4 (604.4491)

FAHFA 16:2/O-24:7

C40H60O4 (604.4491)

FAHFA 16:3/O-24:6

C40H60O4 (604.4491)

FAHFA 16:4/O-24:5

C40H60O4 (604.4491)

FAHFA 16:5/O-24:4

C40H60O4 (604.4491)

FAHFA 17:2/O-23:7

C40H60O4 (604.4491)

FAHFA 17:3/O-23:6

C40H60O4 (604.4491)

FAHFA 17:4/O-23:5

C40H60O4 (604.4491)

FAHFA 17:5/O-23:4

C40H60O4 (604.4491)

FAHFA 18:2/O-22:7

C40H60O4 (604.4491)

FAHFA 18:3/O-22:6

C40H60O4 (604.4491)

FAHFA 18:4/O-22:5

C40H60O4 (604.4491)

FAHFA 18:5/O-22:4

C40H60O4 (604.4491)

FAHFA 18:6/O-22:3

C40H60O4 (604.4491)

FAHFA 19:2/O-21:7

C40H60O4 (604.4491)

FAHFA 19:3/O-21:6

C40H60O4 (604.4491)

FAHFA 19:4/O-21:5

C40H60O4 (604.4491)

FAHFA 19:5/O-21:4

C40H60O4 (604.4491)

FAHFA 19:6/O-21:3

C40H60O4 (604.4491)

FAHFA 20:3/O-20:6

C40H60O4 (604.4491)

FAHFA 20:4/O-20:5

C40H60O4 (604.4491)

FAHFA 20:5/O-20:4

C40H60O4 (604.4491)

FAHFA 20:6/O-20:3

C40H60O4 (604.4491)

FAHFA 21:3/O-19:6

C40H60O4 (604.4491)

FAHFA 21:4/O-19:5

C40H60O4 (604.4491)

FAHFA 21:5/O-19:4

C40H60O4 (604.4491)

FAHFA 21:6/O-19:3

C40H60O4 (604.4491)

FAHFA 21:7/O-19:2

C40H60O4 (604.4491)

FAHFA 22:3/O-18:6

C40H60O4 (604.4491)

FAHFA 22:4/O-18:5

C40H60O4 (604.4491)

FAHFA 22:5/O-18:4

C40H60O4 (604.4491)

FAHFA 22:6/O-18:3

C40H60O4 (604.4491)

FAHFA 22:7/O-18:2

C40H60O4 (604.4491)

FAHFA 23:4/O-17:5

C40H60O4 (604.4491)

FAHFA 23:5/O-17:4

C40H60O4 (604.4491)

FAHFA 23:6/O-17:3

C40H60O4 (604.4491)

FAHFA 23:7/O-17:2

C40H60O4 (604.4491)

FAHFA 24:4/O-16:5

C40H60O4 (604.4491)

FAHFA 24:5/O-16:4

C40H60O4 (604.4491)

FAHFA 24:6/O-16:3

C40H60O4 (604.4491)

FAHFA 24:7/O-16:2

C40H60O4 (604.4491)

FAHFA 25:4/O-15:5

C40H60O4 (604.4491)

FAHFA 25:5/O-15:4

C40H60O4 (604.4491)

FAHFA 25:6/O-15:3

C40H60O4 (604.4491)

FAHFA 25:7/O-15:2

C40H60O4 (604.4491)

FAHFA 26:5/O-14:4

C40H60O4 (604.4491)

FAHFA 26:6/O-14:3

C40H60O4 (604.4491)

FAHFA 26:7/O-14:2

C40H60O4 (604.4491)

FAHFA 40:9;O

C40H60O4 (604.4491)

MGDG 10:0_13:0

C32H60O10 (604.4186)

MGDG 11:0_12:0

C32H60O10 (604.4186)

MGDG 23:0

C32H60O10 (604.4186)

MGDG O-23:1;O

C32H60O10 (604.4186)

MGDG O-24:0

C33H64O9 (604.455)

MGMG 24:0

C33H64O9 (604.455)

MGGA 23:0

C32H60O10 (604.4186)

PA O-14:0/16:1

C33H65O7P (604.4468)

PA O-14:1/16:0

C33H65O7P (604.4468)

PA O-16:0/14:1

C33H65O7P (604.4468)

PA O-16:1/14:0

C33H65O7P (604.4468)

PA O-18:0/11:2;O

C32H61O8P (604.4104)

PA O-18:1/12:0

C33H65O7P (604.4468)

PA O-20:1/10:0

C33H65O7P (604.4468)

PA O-29:2;O

C32H61O8P (604.4104)

PA P-14:0/16:0

C33H65O7P (604.4468)

PA P-14:0/16:0 or PA O-14:1/16:0

C33H65O7P (604.4468)

PA P-16:0/14:0

C33H65O7P (604.4468)

PA P-16:0/14:0 or PA O-16:1/14:0

C33H65O7P (604.4468)

PA P-18:0/12:0

C33H65O7P (604.4468)

PA P-18:0/12:0 or PA O-18:1/12:0

C33H65O7P (604.4468)

PA P-20:0/10:0

C33H65O7P (604.4468)

PA P-20:0/10:0 or PA O-20:1/10:0

C33H65O7P (604.4468)

PA P-20:0/9:1;O

C32H61O8P (604.4104)

PA P-30:0

C33H65O7P (604.4468)

PA P-30:0 or PA O-30:1

C33H65O7P (604.4468)

PA 11:0_18:1

C32H61O8P (604.4104)

PA 12:0_17:1

C32H61O8P (604.4104)

PA 13:0_16:1

C32H61O8P (604.4104)

PA 14:0_15:1

C32H61O8P (604.4104)

PA 14:1_15:0

C32H61O8P (604.4104)

PA 25:0/4:1

C32H61O8P (604.4104)

LPEth 28:1

C33H65O7P (604.4468)

LPM 29:1

C33H65O7P (604.4468)

PEth 27:1

C32H61O8P (604.4104)

PM 28:1

C32H61O8P (604.4104)

CerPE 14:0;O2/16:1

C32H65N2O6P (604.458)

CerPE 14:1;O2/16:0

C32H65N2O6P (604.458)

CerPE 14:2;O2/15:0;O

C31H61N2O7P (604.4216)

CerPE 15:0;O2/15:1

C32H65N2O6P (604.458)

CerPE 15:1;O2/15:0

C32H65N2O6P (604.458)

CerPE 15:2;O2/14:0;O

C31H61N2O7P (604.4216)

CerPE 16:0;O2/14:1

C32H65N2O6P (604.458)

CerPE 16:1;O2/14:0

C32H65N2O6P (604.458)

CerPE 16:2;O2/13:0;O

C31H61N2O7P (604.4216)

CerPE 17:1;O2/13:0

C32H65N2O6P (604.458)

CerPE 17:2;O2/12:0;O

C31H61N2O7P (604.4216)

CerPE 18:1;O2/12:0

C32H65N2O6P (604.458)

CerPE 18:2;O2/11:0;O

C31H61N2O7P (604.4216)

CerPE 19:1;O2/11:0

C32H65N2O6P (604.458)

CerPE 19:2;O2/10:0;O

C31H61N2O7P (604.4216)

CerPE 20:1;O2/10:0

C32H65N2O6P (604.458)

CerPE 29:2;O2;O

C31H61N2O7P (604.4216)

SM 14:1;O2/13:0

C32H65N2O6P (604.458)

SM 14:2;O2/12:0;O

C31H61N2O7P (604.4216)

SM 15:1;O2/12:0

C32H65N2O6P (604.458)

SM 15:2;O2/11:0;O

C31H61N2O7P (604.4216)

SM 16:1;O2/11:0

C32H65N2O6P (604.458)

SM 16:2;O2/10:0;O

C31H61N2O7P (604.4216)

SM 17:1;O2/10:0

C32H65N2O6P (604.458)

SM 26:2;O2;O

C31H61N2O7P (604.4216)

SM 27:1;O2

C32H65N2O6P (604.458)

SM 8:0;O2/19:1

C32H65N2O6P (604.458)

(3s,4ar,6ar,6bs,8as,11r,12s,12as,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O5 (604.4128)

(1r,2s)-2-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(1s,2r)-1,2-dihydroxy-2,6,6-trimethylcyclohexyl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-1,3,3-trimethylcyclohexane-1,2-diol

C40H60O4 (604.4491)

7-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O5 (604.4128)

8a-(hydroxymethyl)-4,4,6a,6b,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1h-picen-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O5 (604.4128)

(2s,3s,4s,5s)-2-{[(1s,2s,3ar,3br,4s,7s,9as,9bs,11ar)-2-hydroxy-4-methoxy-3a,6,6,9b,11a-pentamethyl-1-[(2s)-6-methylhept-5-en-2-yl]-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

C36H60O7 (604.4339)

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-15-[(2r,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbutanoate

C36H60O7 (604.4339)

3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O5 (604.4128)

(1r,4ar,5s,8ar)-5-{[(1s,6s)-6-[(2e)-4-[(1r,4as,5s,8as)-5-carboxy-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]but-2-en-2-yl]-2-methylcyclohex-2-en-1-yl]methyl}-1,4a-dimethyl-7-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C40H60O4 (604.4491)

1-(2-hydroxy-6-methyl-5-methylideneheptan-2-yl)-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl 3-(4-hydroxyphenyl)prop-2-enoate

C40H60O4 (604.4491)

4-[2-(5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)ethyl]-2'-hydroxy-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

C40H60O4 (604.4491)

(1s,2r,5s,10s,14r,15r,16r,20s,25s,28r)-14,28-dihydroxy-14,28-diisopropyl-6,6,10,21,21,25-hexamethylheptacyclo[14.10.2.0²,¹¹.0²,¹⁵.0⁵,¹⁰.0¹⁷,²⁶.0²⁰,²⁵]octacosa-11,17(26)-diene-13,27-dione

C40H60O4 (604.4491)

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5ar,7s,9ar,9br,11r,11ar)-11-hydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2e)-6-methylhepta-2,5-dien-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O7 (604.4339)

(4s,8r,9r,10e,18r)-18-{[(1r,4ar,5r,8ar)-5-carboxy-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]methyl}-8-isopropyl-11,17-dimethyl-5-methylidenetricyclo[12.4.0.0⁴,⁹]octadeca-10,16-diene-1-carboxylic acid

C40H60O4 (604.4491)

(1s,3ar,3br,5ar,7s,9as,9br,11ar)-1-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C40H60O4 (604.4491)

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2z,4e,6e)-7-hydroxy-4-methylnona-2,4,6,8-tetraenoate

C40H60O4 (604.4491)

(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O5 (604.4128)

(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-1-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C40H60O4 (604.4491)

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O7 (604.4339)

2-{[2-hydroxy-4-methoxy-3a,6,6,9b,11a-pentamethyl-1-(6-methylhept-5-en-2-yl)-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

C36H60O7 (604.4339)

3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (4e,6e)-7-hydroxy-4-methylnona-2,4,6,8-tetraenoate

C40H60O4 (604.4491)

(1s,3ar,3br,5as,7s,9ar,9br,11ar)-1-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C40H60O4 (604.4491)

(2r,3r,4s,5s,6r)-2-{[(1s,3ar,3br,5ar,7s,9ar,9br,11r,11ar)-11-hydroxy-3a,3b,6,6,9a-pentamethyl-1-(6-methylhepta-1,5-dien-2-yl)-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O7 (604.4339)

(1s,3as,3br,5ar,7s,9ar,9bs,11as)-1-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-3b,6,6,9a,11a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C40H60O4 (604.4491)

(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-1-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C40H60O4 (604.4491)

8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O5 (604.4128)

(2s,3r,4s,5r)-2-{[(1r,2s,3as,3br,4s,7s,9as,9bs,11ar)-2-hydroxy-4-methoxy-3a,6,6,9b,11a-pentamethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,3bh,4h,7h,8h,9h,9ah,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}oxane-3,4,5-triol

C36H60O7 (604.4339)

(3s,4ar,6ar,6bs,8as,12ar,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O5 (604.4128)

(1r,3as,5ar,5br,7ar,9s,11as,11br,13ar,13bs)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O5 (604.4128)

(10s,25s)-14,28-dihydroxy-14,28-diisopropyl-6,6,10,21,21,25-hexamethylheptacyclo[14.10.2.0²,¹¹.0²,¹⁵.0⁵,¹⁰.0¹⁷,²⁶.0²⁰,²⁵]octacosa-11,17(26)-diene-13,27-dione

C40H60O4 (604.4491)

(1s,3r,6s,8r,11s,12s,15r,16r)-7,7,12,16-tetramethyl-15-[(2r)-6-methylheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl (2z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C40H60O4 (604.4491)

(1r,3ar,5ar,5br,7s,7ar,9s,11ar,11br,13ar,13br)-7-hydroxy-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O5 (604.4128)

(1s,2r,3r,5r,7r,10s,11r,14r,15s)-15-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbutanoate

C36H60O7 (604.4339)

(1s,2r,3r,5r,7s,10s,11r,14r,15s)-15-[(2s,3s,5r)-5-[(1s)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbutanoate

C36H60O7 (604.4339)

5-({6-[4-(5-carboxy-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)but-2-en-2-yl]-2-methylcyclohex-2-en-1-yl}methyl)-1,4a-dimethyl-7-methylidene-hexahydro-2h-naphthalene-1-carboxylic acid

C40H60O4 (604.4491)

15-[5-(1,2-dihydroxy-2-methylpropyl)-2-methoxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbutanoate

C36H60O7 (604.4339)

(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C39H56O5 (604.4128)

(1s,2r,3s,4s)-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-18-[(1s,4s,5r,6s)-4,5-dihydroxy-2,2,6-trimethylcyclohexyl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethylcyclohexane-1,2-diol

C40H60O4 (604.4491)

(1r,1'r,2's,4's,5'r,9's,10's,13'r)-4-{2-[(1r,4ar,8ar)-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]ethyl}-2'-hydroxy-5',9'-dimethyl-15'-oxospiro[cyclohexane-1,14'-tetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan]-3-ene-5'-carboxylic acid

C40H60O4 (604.4491)

2-{[10-hydroxy-9-(hydroxymethyl)-2,2,4a,6a,6b,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicen-4-yl]oxy}-6-methyloxane-3,4,5-triol

C36H60O7 (604.4339)

(1r,4r,8as)-8-{[(1s)-6-[(2z)-4-[(1r,5s,8as)-5-carboxy-5,8a-dimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]but-2-en-2-yl]-2-methylcyclohex-2-en-1-yl]methyl}-4,8a-dimethyl-7-methylidene-octahydronaphthalene-1-carboxylic acid

C40H60O4 (604.4491)

2-{[8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O7 (604.4339)

(1s,3ar,3br,5as,7s,9ar,9br,11ar)-1-[(2s)-2-hydroxy-6-methyl-5-methylideneheptan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C40H60O4 (604.4491)